Aerobiotix
  • Home
  • Products
    • COVID-19
    • Illuvia® HUAIRS
    • Illuvia® Videos
  • Evidence
    • All Evidence
    • Elective Surgery Q&A
    • Clinical Tools
    • Peer Reviewed
    • White Papers
  • News and Events
  • About Us
    • Who We Are
    • Our Goals
    • Leadership Team
CONTACT US
Select Page

Reduction of PJI Rates with supplemental intraoperative air decontamination

Aug 30, 2018

Piatt, C. DO, Cook, T. DO, Accepted for 2018 Annual Meeting American Osteopathic Academy of Orthopedics. PJI rate reduced from 1.8% to 0%.

Reduction of Airborne Bioburden during Lower Limb Total Joint Arthroplasty

Jul 31, 2018

Anis, H. MD, Curtis, G. MD, et al., Cleveland Clinic, Presented at MSIS 2018. This study demonstrated a significant reduction of total and viable particles as well as CFUs in active TJA surgeries.

Canberra Australia Presentation

Jun 1, 2018

Total and Viable airborne particulates during orthopaedic surgical procedures

AAHKS Presentation on C-UVC Disinfection and Recirculation Units

Jun 1, 2018

Curtis, G. et al. AAHKS Presentation on C-UVC units and the reduction of total and viable air particles in the OR.

Presentation on the Effect of a Novel Air Decontamination-recirculation system

Jun 1, 2018

Walsh, W.R., et al Presentation on study of viable and total airborne particulates during surgery.

« Older Entries
Next Entries »

Recent Posts

  • DAYTON INGENUITY: Miamisburg medical device company uses pandemic to clear the air
  • Healthcare Purchasing News Virtual Forum
  • Florida Orthopaedic Society (FOS)
  • APIC Annual Meeting
  • AORN Annual Meeting

Recent Comments

  • A WordPress Commenter on Hello world!

Archives

  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • August 2020
  • July 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • May 2019
  • June 2018
  • March 2018
  • February 2018
  • September 2017
  • July 2017

Categories

  • Blog
  • Clinical Outcome Studies Preview
  • Events
  • Independent Studies and Results Preview
  • News
  • News and Events
  • Pinned
  • Product Materials Preview
  • Uncategorized

Meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

About Aerobiotix

Aerobiotix, Inc. is an innovative company driving leadership in advanced air quality products for the healthcare market. Aerobiotix, Inc. designs, develops, manufactures and markets novel technologies to build healthy environments worldwide.

444 Alexandersville Rd
Miamisburg, Ohio 45342

Phone: +1 888 978 7087

APIC Strategic Partner


Clean Hospitals Member

 

Resources

  • Home
  • Products
    • COVID-19
    • Illuvia® HUAIRS
    • Illuvia® Videos
  • Evidence
    • All Evidence
    • Elective Surgery Q&A
    • Clinical Tools
    • Peer Reviewed
    • White Papers
  • News and Events
  • About Us
    • Who We Are
    • Our Goals
    • Leadership Team
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn

© Aerobiotix, Inc. Illuvia, HUAIRS, Aerobiotix and the A logo are trademarks of Aerobiotix, Inc. Protected by US Patent Numbers 9,433,693 and 9,457,119. Additional US and International Patents Pending. This product is not marketed for the diagnosis, prevention or treatment of disease. Illuvia® has been proven to significantly reduce microbial contamination in the Operating Room. Actual results may vary facility to facility. Please contact an Aerobiotix representative at 1-888-978-7087 to learn more. Privacy Policy